 |
| |
CV Sciences Aktie
| 2,0888 $ | -1,00% | -0,0212 $ |
WKN: A2ALU7
ISIN: US1266541028
US-Symbol:
CVSI
Typ: Aktie
Performance CV Sciences Aktie
| 1 Woche | 1 Monat | 3 Monate | Lfd. Jahr | 1 Jahr | 3 Jahre | |
| Kurs | 2,38 $ | 1,05 $ | 0,414 $ | 0,6175 $ | 0,295 $ | 1,39 $ |
| Änderung | -12,24% | +98,93% | +404,54% | +238,27% | +608,07% | +50,27% |
Nachrichten zur CV Sciences Aktie
| 08.03.18 | OTCQX And OTCQB Companies to Present At 2018 ROTH Conference | PR Newswire |
| 24.07.17 | SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating CV Sciences, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors | PR Newswire |
| 05.06.17 | CV Sciences, Inc. Presentation Now Available for On-Demand Viewing | PR Newswire |
| 30.05.17 | CV Sciences, Inc. to Webcast Live at VirtualInvestorConferences.com June 1, 2017 | PR Newswire |
| 30.05.17 | Live Investor Conference & Webinar: NYSE and OTC companies present June 1st | PR Newswire |
| 24.09.15 | Stevia Corp. Unveils 30 Years of Ground Breaking Cannabis Research at Realhemp.com | PR Newswire |
Forum zur CV Sciences Aktie
Minstacha: Press Release
15.06.18
Link kam grad vor einer Stunde per e-mail
https://ir.cvsciences.com/press-releases/detail/73/cv-sciences-inc-announces-landmark-publication-on-the
Bin gespannt ob es Kursauswirkung hat...
CV Sciences Aktie & Unternehmen
| Branche | Biotechnologie |
| Herkunft | USA |
| Website | cvsciences.com |
| Aktienanzahl | 87,8 Mio. (Stand: 17.09.17) |
| Marktkap. | 183,3 Mio. $ |
Dividenden & Splits
| Keine Daten im genannten Zeitraum vorhanden |
Ähnliche Aktien
| Heat Biologics | 2,04 € | +7,37% | |
| Trevena | 1,45 € | -5,23% | |
| Celgene | 67,05 € | -0,37% | |
| Evofem Biosciences | 3,00 € | +4,53% | |
| Sesen Bio | 1,79 € | -2,72% |
Zum Seitenanfang